We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ring with Lab-on-a-Chip Technology Rapidly Diagnoses STDs in a Single Blood Test

By LabMedica International staff writers
Posted on 08 Sep 2015
A low-cost, point-of-care and personal diagnostics thumb-ring has been successfully developed to test for sexually transmitted diseases (STDs) such as syphilis, gonorrhea, chlamydia, and trichomoniasis, transmitting data to a smartphone where an app quickly presents the results.

The innovative “Hoope” ring was designed by mechanical engineer Ernesto Rodriguez Leal, PhD, from Monterrey (Mexico). "Every year more than 500 million people around the world contract one of these four STDs, 50% are between 15 to 23 years of age. The problem is that 75% do not present early symptoms, therefore the need for an early-detection strategy," he said.

Image: A highly portable personal diagnostic device has been developed in the form of a ring, the “Hoope,” worn on the thumb during testing. Initially the ring will enable rapid early detection of the sexually transmitted diseases (STDs) syphilis, gonorrhea, chlamydia, and trichomoniasis (Photo courtesy of Hoope).
Image: A highly portable personal diagnostic device has been developed in the form of a ring, the “Hoope,” worn on the thumb during testing. Initially the ring will enable rapid early detection of the sexually transmitted diseases (STDs) syphilis, gonorrhea, chlamydia, and trichomoniasis (Photo courtesy of Hoope).

Hoope is placed on the thumb and contains a disposable cartridge with a retractable single-use needle. It also contains an anesthetic system by which an electrical pulse generates numbness, preventing pain at the time of puncture. It is worn only at the time of testing and functions as a personal diagnostic tool. A button is pressed, activating the needle to draw blood, which is transported by capillary action and taken into a lab-on-a-chip, where the blood is distributed into 4 microfluidic channels. "We put antigens specifically synthesized to catch antibodies for each of the diseases,” said Dr. Rodreges Leal, “If antibodies for any of the conditions exists, the antigens trap them and produce an electrochemical reaction."

Data are wirelessly transmitted to a device such as a smartphone or tablet, where an app shows the results in less than a minute. In cases of positive results, the app provides related medical information and a map showing the location of the nearest specialist with whom an appointment can be scheduled.

The Hoope portable device project was developed at a Mexican startup in Silicon Valley. "There I met Damel Mektepbayeva, biotechnologist from Kazakhstan, and Irina Rymshina, Russian finance expert, the three of us decided to create Hoope," explained Dr. Rodríguez Leal. He arrived to Silicon Valley through the Singularity University program consisting of a 3-month stay at NASA that brings together 80 people from around the world. "In this program I learned the tools needed to conceptualize social impact projects and transform the idea from the lab to an end product," he said, "The first prototype was designed at the Colorado State University located in Fort Collins, it showed excellent results in the detection of syphilis, and we are working to perfect it for the other three diseases."

With this technological development the researchers have won several international competitions. The device will be manufactured in China and made available January 2016 through an Indiegogo campaign. A specialized app will also be released. Hoope will initially be marketed in Latin America (later in Europe and the United States) at a price of approximately USD 50 for the ring and three cartridges. Currently the team continues to improve the device, including for its potential to be adapted to detect allergies, cancer, diabetes, and pregnancy.

Related Links:

Hoope
Singularity University 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Latest Technology News

New Diagnostic System Achieves PCR Testing Accuracy

DNA Biosensor Enables Early Diagnosis of Cervical Cancer

Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples